Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment (Q35079602)

6 August 2017

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment (English)

1 reference

6 August 2017

Filicko J

1

1 reference

6 August 2017

Lazarus HM

series ordinal

2

1 reference

6 August 2017

Flomenberg N

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Bone Marrow Transplantation

6 August 2017

1 reference

6 August 2017

31

1 reference

6 August 2017

1

1 reference

6 August 2017

1-10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703776

6 August 2017

0 references

cites work

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Mucositis associated with stem cell transplantation: current status and innovative approaches to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Effect of oral glutamine supplementation during bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Keratinocyte growth regulation by the products of immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Iseganan HCl: a novel antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Infection and mucosal injury in cancer treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

GM-CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Use of radiation with or without WR-2721 in advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703776

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703776

1 reference

6 August 2017

1 reference